Welcome to our dedicated page for Ecolab SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ecolab Inc. (ECL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ecolab is a Delaware corporation with common stock listed on the New York Stock Exchange under the symbol ECL, and it uses SEC filings to report earnings, capital markets activity, governance changes and other material events.
Among the most frequently referenced documents are Form 8‑K current reports. Ecolab files 8‑Ks to announce quarterly earnings results, attaching news releases and supplemental data that describe performance across segments such as Global Water, Global Institutional & Specialty, Global Pest Elimination and Global Life Sciences. Other 8‑Ks disclose events like the issuance of debt securities, including notes issued under the company’s shelf registration statement, and board appointments or committee assignments.
Users can also review filings related to Ecolab’s debt and listing status. For example, a Form 25 filing by the New York Stock Exchange documents the removal from listing of certain Ecolab notes, while the company’s common stock remains listed under ECL. These filings outline the terms of specific securities and the rules relied upon for delisting particular debt instruments.
On Stock Titan, Ecolab’s filings are updated as they appear on EDGAR, and AI-powered tools can help summarize lengthy documents so that readers can quickly understand key points, such as segment commentary in earnings releases, the purpose of new notes offerings, or the significance of board and governance disclosures. Investors interested in ECL can use this page to locate 8‑K earnings reports, registration-related documents, and other filings that shape the company’s regulatory and capital markets profile.
Ecolab Inc. executive Nicholas J. Alfano exercised stock options and sold shares on the same day. He converted 9,501 Employee Stock Options into 9,501 shares of Common Stock at an exercise price of $137.09 per share, then sold 9,501 shares in an open-market transaction at $303.58 per share.
After these transactions, he held 4,721.639 shares of Common Stock directly and 1,481.033 units in the Ecolab Stock Fund of the Ecolab Savings Plan, which the plan reports as the equivalent of approximately 2,715 shares as of January 31, 2026.
A shareholder of ECL filed a Rule 144 notice to sell 9,501 shares of common stock. The shares have an aggregate market value of 2,842,414 and will be sold through Morgan Stanley Smith Barney LLC on the NYSE on or about 02/17/2026. The stock was acquired the same day via an employee stock option exercise using a broker-assisted cashless exercise. Shares outstanding were 283,235,653, providing context for the size of this proposed sale.
Ecolab Inc. director John J. Zillmer exercised stock options and adjusted his shareholdings. On 02/13/2026 he exercised a non-employee stock option for 2,300 shares of common stock at $115.075 per share. In a related transaction, 879 shares of common stock at $301.02 per share were withheld to cover the option exercise price or related tax obligations, as described in the footnotes. After these transactions, he directly beneficially owned 49,012.24 shares of Ecolab common stock.
Ecolab Inc. director Victoria Reich reported stock transactions involving company shares. On February 13, 2026, she exercised a Non-Employee Stock Option for 1,000 shares of Common Stock at an exercise price of $115.075 per share. The option covered Ecolab Common Stock and became exercisable in four three‑month installments following its original grant.
On the same day, she also reported an open-market sale of 1,000 shares of Common Stock at a price of $301.08 per share. After these transactions, she directly owned 25,175.69 shares of Ecolab Common Stock, while the exercised option position was reduced to zero.
Ecolab Inc. senior vice president and corporate controller Jennifer J. Bradway exercised stock options and sold shares of company stock. On 02/13/2026, she exercised an employee stock option for 950 shares of common stock at an exercise price of $137.087 per share, converting a previously granted derivative award under the Ecolab Inc. 2010 Stock Incentive Plan.
On the same day, she sold 613 shares of common stock in an open-market transaction at a price of $302.01 per share. After these transactions, she directly owned 4,706.362 shares of Ecolab common stock, which includes 11.55 shares acquired through automatic dividend reinvestment.
An insider associated with ECL has filed a notice to sell 1,000 shares of common stock under Rule 144. The planned sale has an aggregate market value of 300690 and is to be executed through Morgan Stanley Smith Barney LLC - Executive Services on the NYSE.
The filing shows the shares were acquired on 02/13/2026 through a Non-Employee Director Stock Option Exercise using a broker-assisted cashless exercise, with payment also dated 02/13/2026. The table notes that 283235653 shares of this class of common stock were outstanding.
A holder associated with Ecolab Inc. (ECL) has filed a notice of intent to sell 613 shares of common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney LLC – Executive Services on the NYSE, reflects an aggregate market value of $184,323.
The securities were acquired on 02/13/2026 via an employee stock option exercise for 950 shares, executed as a broker-assisted cashless exercise on the same date. The filing notes that total common shares outstanding were 283,235,653 as of this transaction context.
A shareholder of ECL has filed a Rule 144 notice to sell 7,900 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 02/12/2026.
The filing lists an aggregate market value of 2,398,045 for these shares and notes 283,235,653 shares outstanding. The seller acquired the stock over time via employee stock option exercises and performance-based restricted stock unit vesting, including transactions dated 12/07/2012, 02/20/2013, 02/19/2025, and 02/26/2025.
Ecolab Inc. reported a record fourth quarter and full year 2025, with Q4 net sales of $4.20 billion, up 5%, and reported diluted EPS of $1.98. Adjusted diluted EPS was $2.08, up 15% from $1.81, driven by organic sales growth, margin expansion and productivity gains.
For 2025, net sales reached $16.08 billion and adjusted diluted EPS was $7.53, up from $6.65. All major segments grew sales, with particularly strong operating income growth in Global Institutional & Specialty, Pest Elimination and Life Sciences.
Ecolab expanded its One Ecolab productivity and restructuring initiative, now expecting annualized savings of about $325 million by 2027, alongside anticipated pre-tax charges of approximately $425 million, mainly severance. For 2026, the company targets adjusted diluted EPS of $8.43–$8.63, an increase of 12%–15%, on reported sales growth of 7%–9% and 100–150 basis points of operating margin expansion.
Ecolab Inc. director John J. Zillmer reported acquiring 128 shares of Ecolab common stock on 12/31/2025 at a price of $0 per share. After this transaction, he beneficially owned 47,591.24 shares held directly. The filing notes that this total includes 37.38 shares obtained through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. No derivative securities transactions were reported.